Literature DB >> 28331949

[Nontuberculous mycobacteria].

K Emmerich1, M Fabri2.   

Abstract

Dermatologically relevant nontuberculous mycobacteria (NTM) include Mycobacterium marinum and Mycobacterium ulcerans and different rapidly growing mycobacteria (RGM). RGM are widely present in the environment and are facultative pathogenic. Diagnostic detection of nontuberculous mycobacteria is frequently challenging. Immune-competent individuals mostly develop localized infections. Immune-suppressed patients may present with severe and disseminated disease. In these cases, rapid initiation of medical treatment is important. Moreover, infections with the more aggressive Mycobacterium ulcerans should be treated early. Due to the risk for the development of inducible antibiotic resistance, antibiotic regimes for NTM infections typically require at least two drugs. Surgical treatment should also be considered. This article discusses clinical presentation, diagnostic workup, and in particular antibiotic treatment options for dermatologically relevant infections caused by NTM.

Entities:  

Keywords:  Antibiotics; Buruli ulcer; Fish tank granuloma; Mycobacterium marinum; Mycobacterium ulcerans

Mesh:

Substances:

Year:  2017        PMID: 28331949     DOI: 10.1007/s00105-017-3970-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  21 in total

1.  Occurrence of mycobacteria in biofilm samples.

Authors:  R Schulze-Röbbecke; B Janning; R Fischeder
Journal:  Tuber Lung Dis       Date:  1992-06

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 3.  Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient.

Authors:  Markus Streit; Lorenz M Böhlen; Thomas Hunziker; Stefan Zimmerli; Gion G Tscharner; Helga Nievergelt; Thomas Bodmer; Lasse R Braathen
Journal:  Eur J Dermatol       Date:  2006 Jan-Feb       Impact factor: 3.328

4.  Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

Authors:  K M George; D Chatterjee; G Gunawardana; D Welty; J Hayman; R Lee; P L Small
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

5.  Mycobacterial skin and soft tissue infection.

Authors:  Shu-Hua Wang; Preeti Pancholi
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

6.  An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon.

Authors:  Kevin L Winthrop; Marcy Abrams; Mitchell Yakrus; Ira Schwartz; Janet Ely; Duncan Gillies; Duc J Vugia
Journal:  N Engl J Med       Date:  2002-05-02       Impact factor: 91.245

Review 7.  Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature.

Authors:  J A Jernigan; B M Farr
Journal:  Clin Infect Dis       Date:  2000-08-30       Impact factor: 9.079

8.  Rapidly growing mycobacterial infections after pedicures.

Authors:  Patrick J Sniezek; Brad S Graham; Heidi Byers Busch; Edith R Lederman; Matthew L Lim; Kimberly Poggemyer; Annie Kao; Moise Mizrahi; Gerry Washabaugh; Mitch Yakrus; Kevin Winthrop
Journal:  Arch Dermatol       Date:  2003-05

9.  Mycobacterium chelonae infection: a complication of tattooing.

Authors:  A Sergeant; P Conaglen; I F Laurenson; P Claxton; M E Mathers; G M Kavanagh; M J Tidman
Journal:  Clin Exp Dermatol       Date:  2012-07-25       Impact factor: 3.470

Review 10.  Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria.

Authors:  R J Kothavade; R S Dhurat; S N Mishra; U R Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.